Tadej Pogacar has etched his name into cycling history, securing his fifth Tour de France title and joining an elite group of riders with the most victories in the prestigious race. The 27-year-old Slovenian's triumph in Paris on Sunday not only solidified his reputation as one of the sport's all-time greats but also coincided with a renewed focus on anti-doping measures, casting a familiar shadow over the spectacle.
Pogacar's dominance throughout the Tour was remarkable, especially considering reports of widespread sickness affecting many riders, including potentially himself and several of his UAE-Team Emirates-XRG teammates, during the latter half of the race. His versatility, much like the legendary Eddy Merckx, allows him to excel across all terrains – from time trials and cobbled sections to high mountain stages and even sprints. His respectful demeanour, publicly acknowledging his domestiques and guiding younger teammate Isaac del Toro across the finish line on multiple occasions, has further endeared him to fans.
However, the narrative of this year's Tour was not solely about athletic prowess. The International Testing Agency (ITA) undertook an 'exceptional operation' of night-time anti-doping tests, waking riders at unsocial hours, including Pogacar at 5 am and Jonas Vingegaard at 2 am. While the ITA has not disclosed specific targets, such unusual testing is suspected to be an attempt to gather data on micro-dosing, a method where athletes take small quantities of performance-enhancing drugs like EPO or anabolic steroids to evade detection via the Athlete Biological Passport.
This intensified scrutiny inevitably brought back memories of cycling's troubled past, notably the systemic doping scandal involving Lance Armstrong, whose seven Tour de France titles were expunged from the records. Although there is no suggestion of wrongdoing concerning Pogacar, Vingegaard, or any other rider tested at night this year, the measures underscore the ongoing challenge of maintaining integrity in professional cycling. The World Anti-Doping Agency (WADA) has previously indicated that micro-dosing could bypass existing detection methods, highlighting the need for continuous innovation in anti-doping strategies.
Beyond the individual achievements and anti-doping concerns, the 2026 Tour de France captivated huge crowds, particularly in Paris. The decision to include the scenic cobbled climb of Montmartre and Sacre-Coeur in the final stage, following its successful debut last year, proved immensely popular, with fervent fans lining the streets. The dramatic final stage also saw a 'superhero-style' victory for Mathieu van der Poel on the Champs-Élysées, adding another layer of excitement to a Tour that, despite its underlying complexities, showcased the enduring appeal and vibrant health of professional cycling.